Kimberly Clark Corp (KMB) · Oct 15, 2026 · Earnings

Kimberly-Clark earnings filing offers no numbers, only preliminary-data notice

No new info

Kimberly-Clark’s earnings filing announces preliminary Q3 data but supplies no sales, EPS, margin, or guidance figures to compare.

Kimberly-Clark is in the middle of a major portfolio transformation: shifting toward personal care and health-and-wellness categories while separating much of its tissue business into the Suzano joint venture and preparing to acquire Kenvue.

This filing does not provide the preliminary results it announces. The exhibit says Kimberly-Clark “today provided estimated preliminary financial data for the three months ended September 30, 2026,” but the supplied content contains no revenue, EPS, operating profit, margin, cash flow, or updated outlook figures.

There is therefore no beat, miss, or guidance read. Published Q3 expectations were approximately $1.62 in EPS and $4.158 billion in revenue, but the exhibit supplies neither result for comparison.

Bottom line: As provided, this is a notification rather than an earnings disclosure. It does not change the operating story until the full Q3 numbers and outlook are released.

What to watch next

Full Q3 earnings release and Q&A session

Original filing on SEC EDGAR

More Kimberly Clark Corp news

Kimberly-Clark earnings filing offers no numbers, only preliminary-data notice | KMB Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.